A detailed history of Sargent Investment Group, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Sargent Investment Group, LLC holds 11,835 shares of DXCM stock, worth $825,491. This represents 0.15% of its overall portfolio holdings.

Number of Shares
11,835
Previous 13,265 10.78%
Holding current value
$825,491
Previous $905,000 14.14%
% of portfolio
0.15%
Previous 0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$59.83 - $87.57 $85,556 - $125,225
-1,430 Reduced 10.78%
11,835 $1.03 Million
Q1 2025

May 05, 2025

BUY
$67.74 - $90.75 $898,571 - $1.2 Million
13,265 New
13,265 $905,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Sargent Investment Group, LLC Portfolio

Follow Sargent Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Investment Group, LLC with notifications on news.